110331 Raising awareness on the prevention of NTDs in Europe

Raising awareness of the prevention of neural tube defects in Europe

Bayer HealthCare Pharmaceuticals and IF are continuing their efforts to raise awareness in Europe of the importance of Folic Acid for the prevention of neural tube defects (NTDs) such as Spina Bifida. Various studies show that only a small number of women in Europe use the right amount of Folic Acid at the right time. A recent study from Northern Ireland found that only 19% of the women in the survey had started Folic Acid use before conception. Studies from the Netherlands, Denmark and Spain show similar results. From November 2010 to March 2011, IF has been participating with Bayer in a postcard campaign to motivate policy makers and key influencers to put the prevention of NTDs high on national agendas. In March policy makers were invited to share the important information about Folic Acid and the prevention of neural tube defects by sending the prevention postcard to a woman they know. You can view the postcards on the IF website.
pierre_ralf115.jpg
The publication of the report "Act against Europe's most common birth defects" signaled the start of an intensive Folic Acid awareness campaign

{facebook}


110331 Better career opportunities for people with Spina Biifda and Hydrocephalus

Better career opportunities for people with Spina Bifida and Hydrocephalus in Europe

People with physical disabilities belong to the risk group who have particular problems on the job market. To change this, IF members from Germany, Switzerland and Romania joined "We Empower uS BH", a Leonardo da Vinci project which focuses on the target group of young people with Spina Bifida and Hydrocephalus. Due to their condition, they need special help and special support in the field of vocational education. The project brings together eight partner organisations from five countries, and will include people with Spina Bifida and Hydrocephalus, their already existing self-help associations, and those responsible for their occupational rehabilitation. Together they will develop support tools to improve the career opportunities for people with Spina Bifida and Hydrocephalus.
we_empower_us_bh115.jpg
IF members from Germany, Switzerland and Romania participate in the employment project "We empower uS bH"

{facebook}


110331 Directive on European cross-border healthcare formally adopted

Directive on European cross-border healthcare formally adopted

On February 24, 2011, the Council of Europe formally approved the European Parliament's amendments on a draft directive on the application of patients' rights in cross-border healthcare. Member states will have 30 months (until 2013) to transpose the directive's provision into national legislation. The most obvious beneficiaries will be patients seeking advanced treatments, those living along borders where the nearest hospital is across the line, or those who work in one country but want to get treatment near family members in another country. Each country must establish at least one national contact point for patients to get information about health providers, reimbursement procedures, and when prior authorisation is needed. Patients can choose between public or private doctors.
healthcare_115.jpg
The directive aims to ensure that the necessary requirements for high-quality, safe and efficient cross-border healthcare are being met

{facebook}


Subscribe to our mailing list

Email Format

Font Resizer

Decrease font size Default font size Increase font size

European Year 2014

COFACE Reconciling Work and Family

Eu Flag

Supported by the European Commission - Directorate-General Justice. Integration of People with a Disability - via the PROGRESS programme

With the support of Bayer Healthcare

Arabic ass boobs amd